Clinical trials
Lung Diseases trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 12 |
| Active, not recruiting | 7 |
| Terminated | 3 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 7 |
| Eli Lilly and Company | 3 |
| The University of Queensland | 3 |
| Bayer | 2 |
| Respira Therapeutics, Inc. | 2 |
| Revolution Medicines, Inc. | 2 |
| United Therapeutics | 2 |
| Vertex Pharmaceuticals Incorporated | 2 |
| AIRNA Corporation | 1 |
| Bayside Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 46 |
| Respiratory Tract Diseases | 27 |
| Lung Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 13 |
| Neoplasms | 10 |
| Neoplasms by Site | 8 |
| Respiratory Tract Neoplasms | 8 |
| Bronchial Neoplasms | 7 |
| Carcinoma | 7 |
| Thoracic Neoplasms | 7 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.